At the end of the latest market close, Arbutus Biopharma Corporation (ABUS) was valued at $4.23. In that particular session, Stock kicked-off at the price of $4.25 while reaching the peak value of $4.33 and lowest value recorded on the day was $4.06. The stock current value is $4.16.Recently in News on October 7, 2021, Thinking about buying stock in Tata Motors, New Fortress Energy, Arbutus Biopharma, US Well Services, or Progenity?. InvestorsObserver issues critical PriceWatch Alerts for TTM, NFE, ABUS, USWS, and PROG. You can read further details here
Arbutus Biopharma Corporation had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.14 on 02/09/21, with the lowest value was $2.43 for the same time period, recorded on 05/13/21.
Arbutus Biopharma Corporation (ABUS) full year performance was 27.22%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arbutus Biopharma Corporation shares are logging -29.13% during the 52-week period from high price, and 71.19% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.43 and $5.87.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3293098 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Arbutus Biopharma Corporation (ABUS) recorded performance in the market was 17.18%, having the revenues showcasing 56.98% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 429.31M, as it employees total of 78 workers.
The Analysts eye on Arbutus Biopharma Corporation (ABUS)
During the last month, 0 analysts gave the Arbutus Biopharma Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.35, with a change in the price was noted +1.42. In a similar fashion, Arbutus Biopharma Corporation posted a movement of +51.82% for the period of last 100 days, recording 2,218,207 in trading volumes.
Technical rundown of Arbutus Biopharma Corporation (ABUS)
Raw Stochastic average of Arbutus Biopharma Corporation in the period of last 50 days is set at 71.14%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 42.57%. In the last 20 days, the company’s Stochastic %K was 46.20% and its Stochastic %D was recorded 39.93%.
Considering, the past performance of Arbutus Biopharma Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 17.18%. Additionally, trading for the stock in the period of the last six months notably improved by 30.00%, alongside a boost of 27.22% for the period of the last 12 months. The shares increased approximately by 4.00% in the 7-day charts and went up by -2.12% in the period of the last 30 days. Common stock shares were driven by 56.98% during last recorded quarter.